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Expression of CD27 and ischemia/reperfusion-induced expres-
sion of its ligand Siva in rat kidneys.
Background. Studies identifying genes that are differentially
expressed following induction of acute ischemic injury have been
useful in delineating the pathophysiology of acute renal failure.
Methods. A differential cDNA library screening technique was
used to identify genes that are differentially expressed in rat
kidney following induction of acute ischemic renal injury.
Results. Levels of mRNA with a high homology to that coding
for Siva, a human proapoptotic protein, were increased approxi-
mately 4.5-fold in kidneys obtained from rats within 12 hours
following ischemia, compared to kidneys from sham-operated
rats. A partial cDNA sequence for the rat protein (rat Siva) was
determined that overlaps 92% of the human open reading frame.
The cDNA sequence predicts a protein 177 amino acids in length
with 76% homology to human Siva. Levels of rat Siva in kidneys
were elevated at one, five and seven days post-ischemia. However,
levels in kidneys obtained two days post-ischemia were not
different from those in kidneys from sham-operated controls. In
situ hybridization demonstrated that rat Siva mRNA was ex-
pressed in cells lining damaged sections in the S3 segment of the
proximal tubule at 12 hours and one day post-ischemia. At five
and seven days, Siva mRNA was located in epithelial cells of
regenerating tubules including in papillary proliferations. TdT-
mediated dUTP-biotin nick end-labeling (TUNEL)-positive cells
colocalized with cells containing Siva mRNA. CD27, the receptor
for Siva was localized by immunohistochemistry to sloughed cells
in the lumens of damaged S3 segments at 12 hours post-ischemia
and to cells within papillary proliferations at five days post-injury.
Conclusions. Siva that is produced within the kidney could be a
mediator of apoptosis post-ischemia via an interaction with CD27.
CD27 is a member of the tumor necrosis factor receptor
(TNFR) superfamily. Members of this family which include
tumor necrosis factor receptor 1 (TNFR1) and Fas, are
important regulators of cell growth and cell survival. In
addition to providing co-stimulatory signals for prolifera-
tion, the binding of ligands to TNFR1 or Fas can result in
apoptosis [1]. The mechanism of TNFR1 or Fas-induced
apoptosis requires that an intact 80 amino acid sequence,
termed the death domain, be present in their cytoplasmic
tails [2].
CD27 is not known to be expressed in kidney [1, 2].
However, the expressions of other members of the TNFR
superfamily, such as TNFR1 and Fas, have been described
in renal tissue. Fas is not detected in normal human kidneys
and Fas mRNA is expressed at low levels in normal mouse
kidneys. However, Fas is highly expressed in tubular epi-
thelial cells of diseased renal tissue such as transplanted
human kidneys undergoing acute rejection. In this setting,
its expression is observed in association with apoptosis of
tubular cells [3]. Levels of Fas mRNA and protein are
increased in kidneys of mice rendered endotoxemic, and
also in association with apoptosis along nephron segments
[4].
CD27 is known to be expressed in T and B lymphocytes.
The interaction of CD27 with its ligand CD70, also ex-
pressed in T and B cells, can provide costimulatory signals
for T and B cell proliferation and for immunoglobulin
production in B cells [2, 5]. Unlike TNFR1 and Fas, the
cytoploasmic tail of CD27 lacks a death domain. However,
the interaction between CD70 and CD27 can induce apo-
ptosis [2].
Recently Prasad et al, using the yeast two-hybrid system,
cloned a novel ligand for CD27 from a HeLa cell cDNA
library, which they designated Siva. Siva has a death
domain-like region that binds to the CD27 cytoplasmic tail
in vitro. In addition, Siva has a B-box-like ring finger
domain [2]. Overexpression of Siva in a number of cell lines
induces apoptosis in the absence of CD70. Presumably, the
association of CD27 in the cell membrane with intracellular
Siva results in apoptosis [2]. Unlike CD70, Siva is present in
a number of non-lymphatic tissues such as prostate, testis,
ovary and colon [2].
We report here, the cloning and sequence characteriza-
tion of rat Siva, its time course of expression, and the
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spacial expression pattern of Siva and its receptor CD27 in
ischemic kidney. The findings represent the initial cloning
of rat Siva and the first demonstrations of Siva and CD27
expression in the kidney. It is possible that an interaction
between the death domain of Siva and CD27 mediates
apoptosis of renal cells following ischemic/reperfusion in-
jury.
METHODS
Animals
Male Sprague-Dawley rats (Harlan, Indianapolis, IN,
USA) weighing approximately 250 g were housed with
12:12 hours light/dark cycle and food and water available ad
libitum.
Induction of acute renal failure
Acute renal failure was induced by 60 minutes of bilat-
eral renal artery clamping as described previously [6, 7]
with sham-operated controls included at each time point.
To control for the extent of renal injury during the proce-
dure, animals were selected such that the level of serum
creatinine measured 24 hours following injury fell into the
range used in previous studies [6–8]. Levels in groups of
rats (mean 6 SE, N 5 3 rats) were 4.2 6 0.3; 3.2 6 0.5; 3.0 6
0.3; and 3.5 6 0.1 mg/dl in groups of rats used to obtain
kidneys one, two, five, and seven days post-ischemia, re-
spectively. Levels were 1.0 6 0.1 and 2.6 6 0.1 mg/dl (N 5
3 rats) at 1 and 12 hours post-injury in the groups of rats
that were sacrificed at these times. Levels of serum creat-
inine in sham-operated rats were measured at the time of
sacrifice and averaged 0.6 6 0.01 mg/dl (N 5 36). These
levels did not differ significantly from group to group.
Levels of serum creatinine at the time of sacrifice of rats
that had been rendered ischemic were 2.0 6 1.2, 0.8 6 0.1,
and 0.7 6 0.1 mg/dl at two, five, and seven days post-injury,
respectively.
Isolation of kidney RNA
At the time points indicated above, rats were anesthe-
tized with ketamine and pentobarbital. Their kidneys were
perfused with sterile phosphate-buffered saline to remove
blood from the organs [7], quickly excised, frozen in liquid
nitrogen and stored at 270°C. Total RNA was isolated
using the Ultraspec RNA isolation solution (Biotecx, Hous-
ton, TX, USA).
Differential library screening
A small fraction of a cDNA library generated from
kidneys of adult rats rendered ischemic [8, 9] was plated on
a Nunc bioassay dish (Fisher, Pittsburgh, PA, USA). Rep-
lica filters were made from the plates on zeta probe
membranes (BioRad, Hercules, CA, USA). Total RNA was
isolated from kidneys of sham-operated rats and rats
rendered ischemic at 24 hours post-surgery. For differential
library screening, first strand 32P-labeled cDNA was syn-
thesized from 5 mg of total RNA using superscript reverse
transcriptase (BRL, Bethesda, MD, USA). One of the
replica filters was then hybridized to the cDNA probe from
sham-operated kidney, and the second filter was hybridized
to the probe from ischemic kidney. The hybridization and
washing conditions used were those recommended by the
manufacturer of the zeta probe. The hybridized filters were
then exposed to X-ray films for two days at 270°C and the
autoradiograms aligned with each other. The plaques that
exhibited differential hybridization were isolated and their
differential expression confirmed by Northern blot hybrid-
izations.
DNA sequencing
Both strands of the cDNA were completely sequenced by
primer walking on an automated ABI377 sequencing ma-
chine. Sequences were searched against the GenBank
nucleotide database using the BLASTN program [10] and
through a non-redundant protein database using the
BLASTX program.
Northern blot analysis
Northern blots were probed as described before [8, 9]
using a fragment containing bases 226 to 630 of the rat
Siva cDNA (Fig. 1). To confirm that equal quantities of
RNA were loaded onto each lane, 18S and 28S bands on an
agarose gel were stained using eithidium bromide, and it
was determined that staining was the same in each lane.
The band intensity after hybridization was measured using
a Phosphorimager and the statistical analysis performed as
before [8, 9]. Comparison between gels was accomplished
by normalizing data to the value of the respective band
originating from a kidney of a sham-operated rat.
Statistical analysis was performed using the Student’s
t-test for unpaired sample means. P , 0.05 for two-tailed
analysis was considered significant.
In situ hybridization
In situ hybridization was performed on tissue sections
originating from sham operated rats and rats rendered
ischemic as previously described [8, 9]. A rat Siva cDNA
cloned in plasmid pBK-CMV (Stratagene, La Jolla, CA,
USA) was used as the template to generate digoxigenin-
11-dUTP labeled sense and antisense riboprobes. A frag-
ment containing bases from 226 to 630 was used as the
sense and antisense probes.
Reverse transcriptase-polymerase chain reaction
(RT-PCR)
Deoxyribonuclease treated total RNA was reverse tran-
scribed using a random oligonucleotide primer using Su-
perscript reverse transcriptase (BRL, Bethesda, MD, USA)
in a 40 ml reaction volume. Twenty microliters of the
reaction was then PCR amplified using CD27 receptor
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specific oligonucleotides: 59-CACCTCCCTACTGGCTCTG
and 59-CACTCTGTACATTCCTGGTC. The oligonucleo-
tide sequences were derived from the published mouse
sequence [11]. The 348 bp PCR fragment amplified from
the rat RNA was cloned into the plasmid vector pGEM-T
(Promega, Madison, WI, USA) and confirmed to represent
the rat CD27 homologue by sequence characterization.
Control PCR amplifications were performed in the absence
of RT.
Western blotting
Whole kidneys from rats were homogenized in cold
buffer (20 mM Tris-HCl, pH 7.5, 250 mM sucrose, 10 mM
EGTA, 1 mM EDTA, 1 mM PMSF, 20 mg/ml leupeptin, 1%
Nonidet P40). Homogenates were centrifuged at 1000 3 g
for 10 minutes at 4°C to remove the nuclear fraction and
debris. The supernatant was centrifuged at 100,000 3 g for
one hour at 4°C to separate the soluble (cytosolic) fraction
from the membrane fraction. The membrane fraction was
resuspended to half the original volume using the homog-
enization buffer to which Triton X-100 was added to a final
concentration to 0.3%. Twenty micrograms of protein was
fractionated on a 4 to 20% gradient polyacrylamide gel and
transferred to a nitrocellulose membrane. The membranes
were incubated in 3% non-fat milk in Tris-buffered saline
containing 0.05% Triton X-100 for one hour, then at 4°C
overnight with, M-20, a CD27-specific primary antibody
(Santa Cruz Biotechnology, Santa Cruz, CA, USA) in
Tris-buffered saline. M-20 is an affinity-purified goat poly-
clonal antibody raised against a peptide corresponding to
amino acids 230 to 249 mapping at the carboxy terminus of
the mouse CD27 precursor. M-20 reacts with CD27 of
mouse and rat origin and is not cross-reactive with other
TNFR family members (Santa Cruz Biotechnology; unpub-
lished observations).
The membranes were washed and incubated with horse-
radish peroxidase conjugated anti-goat antibody (Pierce,
Rockford, IL, USA) for one hour at room temperature.
Fig. 1. (A) cDNA and deduced amino acid sequence for rat Siva, and (B) comparison between rat (R) Siva and human (H) Siva. D defines the death
domain and B defines the B-box-like region.
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The reaction products were visualized using ECL-chemilu-
minescence kit (Amersham, Arlington Heights, IL, USA).
Tissue staining
Localization of CD27 was performed by immunofluores-
cent staining of 5 mm Bouins-fixed paraffin-embedded
sections as described previously [12]. The primary antibod-
ies were M20, obtained from Santa Cruz Biotechnology,
Inc. The sections were deparaffinized in xylene, rehydrated
in graded ethanol, washed in phosphate-buffered saline
(PBS) followed by blocking in a PBS buffer containing 10%
rabbit serum and 0.2% triton X-100 for two hours. The
sections were incubated overnight at 4°C with the primary
antibodies (2 mg/ml) in 1% rabbit serum and 0.2% triton
X-100. Cy3 linked donkey anti-goat IgG was used as
secondary antibodies. For blocking experiments, 2 mg of
CD27 antibody was resuspended in 900 ml of PBS and
incubated overnight at 4°C with 10 mg of blocking peptide
(SC1743p) or a scrambled peptide (SC1744p; Santa Cruz
Biotechnology). TdT-mediated dUTP-biotin nick end-la-
beling (TUNEL) staining was used to identify apoptotic
cells as before [12].
RESULTS
To identify genes that are expressed following ischemia/
reperfusion injury, we performed differential library
screening. A cDNA library generated from kidneys from
rats rendered ischemic one day previously was screened
using cDNA probes generated from kidneys of either sham
operated rats or rats rendered ischemic. Several plaques
were identified that: (1) either failed to hybridize or
hybridized weakly to the probe originating from sham-
operated rats; and (2) hybridized strongly to the probe from
ischemic rats. One clone, upon sequence characterization
was found to have high homology to the human proapop-
totic protein, Siva cDNA.
Translation of the partial rat Siva open reading frame
revealed a primary sequence 177 amino acids long (Fig.
1A) with high homology (76%) to the comparable portions
of human Siva (Fig. 1B), which is 189 amino acids long [2].
Fifty-three of 75 amino acids are conserved within the
death domain (71% homology; Fig. 1B). Therefore, the
homology between the death domains of rat and human
Siva is higher than that between human Siva and the death
Fig. 2. Northern assay for Siva mRNA and the effect of ischemia on renal Siva mRNA levels. (Inset) A representative autoradiogram of a Northern
blot generated using RNA from kidneys of three rats that underwent sham-surgery and three rats rendered ischemic five days previously. The size of
the RNA species (800 bp) is shown. Also shown are results from three Northern assays quantified using a phosphorimager. N 5 3 rats in each group.
Data are mean 6 SE. ARF . sham at 12 hours, and one, five and seven days (P , 0.05, Student’s t-test). Symbols are: (M) sham; (f) ARF.
Padanilam et al: CD27 and Siva expression1970
domains of the human proteins FADD or RIP (40%) [2].
Twenty-nine of 32 animo acids in the B-box-like ring finger
region [2] of rat Siva are homologous to those in human
Siva (Fig. 1B).
To characterize the time course of renal rat Siva expres-
sion post-ischemic injury, kidneys were obtained from
sham-operated rats and rats rendered ischemic, one and 12
hours, and one, two, five, and seven days post-sham surgery
or post-ischemia, and Northern assays were performed
using RNA extracted from the kidneys. A representative
autoradiogram of a gel from a Northern assay originating
from mRNA extracted from three kidneys obtained five
days post-ischemia or sham surgery is shown in Figure 2
(upper right). Rat Siva mRNA (800 bp band) was visibly
increased in kidneys from rats rendered ischemic relative to
levels in kidneys from sham-operated animals.
Levels of rat Siva mRNA in kidneys of three groups of
rats subjected to sham-surgery or ischemic injury at 12
hours, and one, two, five or seven days prior to sacrifice
determined by Northern analysis were quantified using a
phosphorimager. The level of rat Siva mRNA in kidneys
from rats subjected to ischemic injury was not significantly
increased compared to that in kidneys from sham-operated
rats at one hour post-injury. However, by 12 hours, the
increase in levels of rat Siva mRNA was approximately
4.5-fold. Levels of rat Siva mRNA in kidneys from rats
subjected to injury were elevated significantly (P , 0.05)
compared to levels in kidneys from sham-operated rats at
12 hours, and one, five and seven days post-injury, but not
at two days post-injury (Fig. 2).
Rat Siva mRNA expression in kidney was localized using
in situ hybridization. The pattern of expression did not
differ among sham-operated rats sacrificed at varying times
post-surgery (not shown). Figures 3 and 4 show photomi-
crograph sections originating from the inner cortex and
outer medulla of kidneys in sham-operated rats (Fig. 3D)
or ischemic rats (Fig. 3 A-C, E, F) sacrificed at 12 hours
(Fig. 3 A-C), one day (Fig. 4 A-C), five days (Fig. 3 D-F),
or seven days (Fig. 4 D, E) post-surgery. Little or no
hybridization is observed when a sense control probe is
used at 12 hours (not shown) or five days post-ischemia
(Fig. 3F). Little rat Siva mRNA is present in tubules of
Fig. 3. Localization of renal Siva mRNA by non-isotopic in situ hybridization. Siva mRNA in kidneys from rats subjected to sham-surgery (D) or
rendered ischemic (A-C, E, F) 12 hours (A-C) or five days prior to sacrifice (E, F), was localized using a digoxigenin labeled antisense riboprobe (A-E)
or sense probe (F). Arrow points towards renal papilla (B). Arrowhead shows ischemic proximal tubule (C). P, papillary proliferation (E,F). Sections
are representative of . 5 experiments. A3C are progressive enlargements of the same section. Magnification (15 mm) is shown for C-F (F).
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Fig. 4. TUNEL staining and localization of renal Siva mRNA by non-isotopic in situ hybridization. TUNEL staining was performed in kidneys from rats
rendered ischemic one day (B, C) or seven days (E) prior to sacrifice. TdT was omitted in the experiment illustrated in B. Siva mRNA in kidneys from rats
rendered ischemic one day (A) or seven days prior to sacrifice (D) was localized as in Figure 3. Arrowheads show cells sloughed within ischemic renal
tubules (A-C). P, papillary proliferation (D, E). Non-serial sections are shown representative of . 5 experiments. Magnification (10 mm) is shown (E).
Fig. 6. Immunohistochemical localization of CD27 in kidneys. CD27 peptide in kidneys from rats rendered ischemic 12 hours (A, B) 24 hours (D, E)
or five days (C) prior to sacrifice was localized using an antibody generated against CD27 (B, C), anti-CD27 together with scrambled peptide (D),
blocking peptide (E) or control antibody (A). Arrowhead points out sloughed cells within the lumen of tubules (B). Papillary proliferations are shown
(p) (C). Sections are representative of . 5 experiments. Magnification (10 mm) is shown (C).
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kidneys from sham-operated rats (Fig. 3D). Rat Siva
mRNA is localized to cells within ischemic tubules of the S3
proximal segment at 12 hours post-injury (Figs. 3 A-C), and
at one day post-injury (Fig. 4A) and in papillary prolifera-
tions (p) within regenerating tubules at five days post-injury
(Fig. 3E), and seven days post-injury (Fig. 4D). In addition
to papillary proliferations, rat Siva mRNA is expressed in
simplified (flattened) epithelial cells lining dilated regener-
ating segments (Fig. 3E). Siva mRNA is expressed at no
other locations in the kidney. A sense probe was used in
Figure 3F.
In non-serial sections, TUNEL positive cells were
present at the same locations as were cells staining for Siva
mRNA that had been sloughed into ischemic tubules in the
S3 segment, or that were present in papillary proliferations.
This is illustrated in photomicrographs of kidneys obtained
from rats one day post-ischemia (Fig. 4 A, C) or seven days
post-ischemia (Fig. 4 D, E). Figure 4B shows the results of
a control experiment performed without TdT [12].
To determine whether CD27, the ligand for Siva, is
expressed in rat kidney, we amplified cDNAs in reverse-
transcribed extracts of mouse or rat kidneys using PCR and
CD27-specific primers, and performed Western blots of rat
renal extracts.
As shown in Figure 5A, CD27 mRNA was present in
mouse (M) and rat (R) kidney extracts. The size of the
amplified cDNA product (348 bp) was identical. No band
was observed if reverse transcriptase was omitted from the
reaction (C). Western blots of proteins extracted from rat
kidneys showed antibody binding to a single 55 kD band in
membrane (Mm), but not in soluble (S) fractions of rat
kidney (Fig. 5B). These results show that CD27 is present
in kidney as a transmembrane dimer composed of 55 kD
monomers, as expected [13].
The localization of CD27 protein in kidney is shown in
Figure 6. In sections originating in kidneys obtained 12
hours (Fig. 6B) and five days (Fig. 6C) post-ischemia,
immunoreactivity is observed only in sloughed cells within
the S3 segments of the proximal tubule (Fig. 6B) and in
papillary proliferations (p) (Fig. 6C). Unlike rat Siva
mRNA (Fig. 3E), CD27 protein is absent from epithelial
cells lining regenerating tubules (Fig. 6C). Figure 6 A, D,
and E show tissue for which the control antibody was
substituted for anti-CD27 (Fig. 6A), or tissue exposed to
anti-CD27 together with CD27 scrambled peptide (Fig.
6D), or blocking peptide (Fig. 6E). Staining was inhibited
by blocking peptide (Fig. 6E), but not scrambled peptide
(Fig. 6D).
DISCUSSION
Apoptosis is an unusual event in normal mature kidney.
However, following induction of acute ischemic renal injury
in the rat, apoptosis is observed in regenerating tubules [14,
15]. Apoptotic cells at the site of regeneration have been
identified by light microscopy [14], electron microscopy [15]
and, to our knowledge, for the first time using TUNEL-
staining (Fig. 4).
Two peaks of apoptosis have been described following
ischemia. The first peak coincides with a burst of prolifer-
ative activity that is maximal at two to three days post-injury
[15]. Between days 3 and 6 post-ischemia, the percentage of
cells undergoing apoptosis falls. However, the incidence of
apoptosis increases again on day 7 and is maximal on day 8
following injury, after which the incidence again declines
slowly over a period of weeks [15]. Hyperproliferation
during days 2 to 3 results in a stratification of hyperplastic
epithelial cells that is demonstrable two to four days
post-injury and in a hyperplasia of circumferential epithe-
lial cells with focal papillary projections that are evident at
5 to 7 days [15, 16]. Epithelial cells in papillary clusters
desquamate into the tubular lumen in the early repair
phase and this process appears to reflect the first peak of
apoptosis. The hyperplastic tubules are returned to their
original cellularity and papillary proliferations are remod-
eled through a wave of apoptosis that is reflected by the
second peak [15].
Fig. 5. (A) Reverse transcribed-polymerase
chain reaction (RT-PCR) of rat kidney RNA
extract and (B) Western blot of rat kidney
extracts. (A) Size markers (left) and the size of
the amplified CD27 cDNA product is shown
(right). Abbreviations are: C, control (no
reverse transcriptase); M, mouse kidney; R, rat
kidney. (B) The size of the CD27 monomer is
shown (right). Abbreviations are: Mm,
membrane fraction; S, soluble extract.
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The existence of a predictable pattern of apoptosis in
kidney during recovery following ischemic injury indicates
that this process is an important one. However, relatively
little is known about its regulation. One approach to
provide insight into its regulation post-ischemia is to define
changes within kidney in the expression of factors known to
regulate programmed cell death. We have shown that the
expressions of the regulatory protooncogenes, bcl-2 and
bax, are enhanced in regenerating S3 segments following
ischemic injury in the rat [16]. The changes in bcl-2 and bax
expression that we describe post-ischemia may or may not
control apoptosis in regenerating S3 segments. However,
bcl-2 is known to play a major anti-apoptotic role during
kidney development [17]. Since the process of renal regen-
eration post-ischemia is similar in many ways to develop-
ment, a role for bcl-2, and perhaps for the related protein,
bax, in the former process would not be unexpected [16,
17].
Presently, we show that a rat homologue of the human
gene Siva is expressed in the S3 segment of proximal
tubules and in papillary proliferations at times (12 hr to 1
day and 5 to 7 days post-injury, respectively) that roughly
parallel the two peaks of apoptosis that occur at this site
post-ischemia [15]. In contrast, enhanced expression is not
observed at an intermediate time (2 days post-injury).
CD27, a ligand for Siva, is expressed in injured kidney
tissue at 12 hours and five days post-injury within sloughed
cells (12 hr) and cells within papillary proliferations (5 days;
Fig. 6). In each of these locations at each of these times, its
ligand, Siva, is also expressed (Fig. 3). These are the cell
populations known to be undergoing death via apoptosis or
necrosis at these times (Fig. 4) [14–16]. Our findings are
consistent with a role of Siva acting through CD27 in the
apoptosis that occurs in the rat proximal tubule following
ischemic injury, although they do not establish such a role.
Enhanced expression of members of the TNFR super-
family and ligands for these receptors occurs in ischemic
kidney [3, 4] and in ischemic organs in addition to kidney.
For example, hepatic ischemia/reperfusion injury in rats
results in tumor necrosis factor (TNF) production in liver.
Pretreatment of rats rendered ischemic with anti-TNF
antiserum attenuates the injury [18].
Also in rats, TNF is expressed in neurons, glial cells,
endothelial cells and infiltrating polymorphonuclear leuko-
cytes within ipsilateral cerebral cortex, within four to six
hours after permanent occlusion of the middle cerebral
artery. In addition, within six hours of artery occlusion, the
expressions of TNFR1 and TNFR2 are enhanced in neu-
rons within ischemic cortex. Immunoreactive TNFRs are
present in neurons undergoing apoptosis [19].
It is proposed that the relative overproduction of TNF
amplifies and extends the severity of cell death during brain
ischemia. Therapeutic implications for this proposal are
demonstrated by the attenuation of brain damage post-
ischemia following the intra-cerebroventricular administra-
tion of anti-TNF antibodies or receptor constructs [19]. As
is the case for TNF-TNFR, antibodies have been generated
against CD27 that modify effects of its ligation [20].
To our knowledge, ours is the first report of Siva and
CD27 expression in kidney. The ligation of CD27 with Siva
can induce apoptosis in vitro [2]. However, the the mecha-
nism by which CD27 ligation with Siva induces apoptosis in
vitro is unknown. Furthermore, the existence of CD27-Siva
protein complexes in vivo and the role of Siva in CD27-
mediated apoptosis in vivo are unproven. Our demonstra-
tion that Siva and CD27 are expressed in kidney following
renal ischemia does not define a causative role of Siva-
CD27 for renal apoptosis. Nonetheless, as is the case in
brain for TNF and TNFRs, it is possible that strategies
directed at modifying CD27-mediated renal apoptosis will
impact positively on the course of acute ischemic renal
injury. Their success will depend on an expanded under-
standing of the role that apoptosis plays in the regenerative
process, as they could be aimed at accelerating the pro-
grammed death of damaged cells [21, 22], or at limiting it
[22, 23].
ACKNOWLEDGMENTS
B.J.P. and M.R.H. were supported by a grant from Bayer Corporation
and by grant DK45181 from NIH. A.J.P.L. was supported by Barnes-
Jewish Hospital, St. Louis, MO.
Reprint requests to Marc R. Hammerman, M.D., Renal Division, Box 8126,
Department of Medicine, Washington University School of Medicine, 660 S.
Euclid Ave., St. Louis, Missouri 63110, USA.
E-mail: mhammerm@imgate.wustl.edu
REFERENCES
1. NAGATA S, GOLSTEIN P: The Fas death factor. Science 267:1449–1456,
1995
2. PRASAD KVS, AO Z, YOON Y, WU MX, RIZK M, JACQUOT S,
SCHLOSSMAN SF: CD27 a member of the tumor necrosis factor
receptor family, induces apoptosis and binds to Siva, a proapoptotic
protein. Proc Natl Acad Sci USA 94:6346–6351, 1997
3. KATO S, AKASAKA Y, KAWAMURA S: Fas antigen expression and its
relationship with apoptosis in transplanted kidney. Pathol Int 47:230–
237, 1997
4. ORTIZ-ARDUAN A, DANOFF TM, KALLURI R, GONZALEZ-CUADRADO
S, KARP SL, ELKON K, EGIDO J, NEILSON EG: Regulation of Fas and
Fas ligand expression in cultured murine renal cells and in the kidney
during endotoxemia. Am J Physiol 271:F1193–F1201, 1996
5. HINTZEN RQ, LENS SMA, KOOPMAN G, PALS ST, SPITS H, VAN LIER
RAW: CD70 represents the human ligand for CD27. Int Immunol
6:477–480, 1994
6. PADANILAM BJ, MARTIN DR, HAMMERMAN MR: Insulin-like growth
factor I-enhanced renal expression of osteopontin after acute ischemic
injury in rats. Endocrinology 137:2133–2140, 1996
7. MILLER SB, MARTIN DR, KISSANE J, HAMMERMAN, MR: IGF-I
accelerates recovery from acute ischemic tubular necrosis in the rat.
Proc Natl Acad Sci USA 89:11876–11880, 1992
8. PADANILAM BJ, HAMMERMAN MR: Ischemia-induced receptor for
activated C kinase (RACK1) expression in rat kidneys. Am J Physiol
272:F160–F166, 1997
9. LEWINGTON AJP, PADANILAM BJ, HAMMERMAN, MR: Induction of
calcyclin after ischemic injury to rat kidney. Am J Physiol 273:F380–
F385, 1997
Padanilam et al: CD27 and Siva expression1974
10. ALTSCHUL SF, GISH W, MILLER W, MYERS EW, LIPMAN, DJ: Basic
local alignment search tool. J Molec Biol 215:403–410, 1990
11. GRAVESTEIN LA, BLOM B, NOLTEN LA, DE VRIES E, VAN DER HORST
G, OSSENDORP F, BORST J, LOENEN WA: Cloning and expression of
murine CD27: Comparison with 4–1BB, another lymphocyte-specific
member of the nerve growth factor receptor family. Eur J Immunol
23:943–950, 1993
12. SORENSON CM, PADANILAM BJ, HAMMERMAN MR: Abnormal post-
partum renal development and cystogenesis in the bcl-22/2 mouse.
Am J Physiol 271:F184–F193, 1996
13. KOBATA T, AGEMATSU K, KAMEOKA J, SCHLOSSMAN SF, MORIMOTO C:
CD27 is a signal-transducing molecule involved in CD45RA1 naive
cell costimulation. J Immunol 153:5422–5432, 1994
14. SCHUMER M, COLOMBEL MC, SAWCZUK TS, GLOBE G, CONNOR J,
O’TOOLE KM, OLSSON CA, WISE GJ, BUTTYAN R: Morphologic,
biochemical and molecular evidence of apoptosis during the reperfu-
sion phase after brief periods of renal ischemia. Am J Pathol 140:831–
838, 1992
15. SHIMIZU A, YAMANAKA N: Apoptosis and cell desquamation in repair
process of ischemic tubular necrosis. Virchows Archiv B Cell Pathol
64:171–180, 1993
16. BASILE DP, LIAPIS H, HAMMERMAN MR: Expression of bcl-2 and bax
in regenerating rat renal tubules following ischemic injury. Am J
Physiol 272:F640–F647, 1997
17. SORENSON CM, ROGERS SA, KORSMEYER SJ, HAMMERMAN, MR:
Fulminant metanephric apoptosis and abnormal kidney development
in bcl-2-deficient mice. Am J Physiol 268:F73–F81, 1995
18. COLLETTI LM, REMICK DG, BURTCH GD, KUNKEL SL, STREITER RM,
CAMPBELL DA JR: Role of tumor necrosis factor-a in the pathophys-
iologic alterations after hepatic ischemia/reperfusion injury in the rat.
J Clin Invest 85:1936–1943, 1990
19. BOTCHKINA GI, MEISTRELL ME III, BOTCHKINA IL, TRACEY KJ:
Expression of TNF and TNF receptors (p55 and p75) in the rat brain
after focal cerebral ischemia. Molec Med 3:765–781, 1997
20. KOBATA T, JACQUOT S, KOZLOWSKI S, AGEMATSU K, SCHLOSSMAN SF,
MORIMOTO C: CD-27-CD70 interactions regulate B-cell activation by
T cells. Proc Natl Acad Sci USA 92:11249–11253, 1995
21. HAMMERMAN MR: Renal programmed cell death and the treatment
of renal disease. Curr Opin Nephrol Hypertens 7:1–3, 1998
22. SAVILL J: Apoptosis and the kidney. J Am Soc Nephrol 5:12–21, 1994
23. LIEBERTHAL W, LEVINE JS: Mechanisms of apoptosis and its potential
role in renal tubular epithelial cell injury. Am J Physiol 271:F477–
F488, 1996
Padanilam et al: CD27 and Siva expression 1975
